Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial

NCT05112328 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05112328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 7, 2021
Completion date
July 31, 2026
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, enteral feeding, exocrine pancreatic insufficiency